Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00087204
Status:
COMPLETED
Last Update Posted:
2013-01-23
First Post:
2004-07-08
Brief Title:
Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Myelodysplastic Syndrome Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Secondary Myelodysplastic Syndromes |
| Adult Acute Myeloid Leukemia With 11q23 MLL Abnormalities |
| Adult Acute Myeloid Leukemia With Inv16p13q22 |
| Adult Acute Myeloid Leukemia With t1517q22q12 |
| Adult Acute Myeloid Leukemia With t1616p13q22 |
| Adult Acute Myeloid Leukemia With t821q22q22 |
| Blastic Phase Chronic Myelogenous Leukemia |
| Chronic Myelomonocytic Leukemia |
| de Novo Myelodysplastic Syndromes |
| Previously Treated Myelodysplastic Syndromes |
| Recurrent Adult Acute Lymphoblastic Leukemia |
| Recurrent Adult Acute Myeloid Leukemia |
| Refractory Anemia With Excess Blasts |
| Refractory Anemia With Excess Blasts in Transformation |
| Relapsing Chronic Myelogenous Leukemia |
| Secondary Acute Myeloid Leukemia |
Keywords: